Research Opportunities

Partnering for New Findings

Clinical trials are a major step to translate pharmacological potential into clinical safety & efficacy

  • =NeuroAiD™, our first product for post-stroke recovery, was commercialized for the first time in Singapore in 2006.
  • =It is today available in over 35 countries in South-East Asia, Europe, Africa and Middle-East.


We bring together the world’s top scientists in molecular biology, pharmacology and brain injuries to conduct our research and development on the principles of Evidence-Based Medicine.

The research on NeuroAiD™ is still very active in post-stroke recover but also in new indications for NeuroAiD™ such as traumatic brain injuries and neurodegenerative diseases (i.e. Alzheimer disease). On average, 4 to 5 papers are published each year by independent researchers, and communicated in international conferences on stroke.

Contact Us

If you represent an institution interested in academic partnerships for clinical trial in:

  • =Post Stroke Recovery
  • =Neurosurgical Diseases
  • =Neurodegenerative Diseases

Please contact us at

We will be pleased to have you and your team extending the knowledge of our innovative and promising products.

Clinical Partnership

This form will be sent directly to for Research Opportunities.
  • This field is for validation purposes and should be left unchanged.